Alexza Pharmaceuticals (ALXA): Q4 EPS of -$0.65. Revenue of $729K. (PR)

 Alexza Pharmaceuticals (ALXA): Q4 EPS of -$0.65. Revenue of $729K. (PR)
Comments (1)
  • Yabadabadoo
    , contributor
    Comments (364) | Send Message
    Just listened to the broadcast. I was hoping the earnings report would bring the stock down so I can buy more.
    Earnings are meaningless for a company with a newly approved drug in the US and Europe.
    The broadcast was very informative.
    26 Mar 2013, 05:47 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs